Core Scientific Toekomstige groei
Future criteriumcontroles 5/6
De verwachting is dat Core Scientific de winst en omzet met respectievelijk 78.6% en 31.7% per jaar zal laten groeien, terwijl de winst per aandeel naar verwachting zal groeien met 85.1% per jaar.
Belangrijke informatie
78.6%
Groei van de winst
85.06%
Groei van de winst per aandeel
| Software winstgroei | 19.7% |
| Inkomstengroei | 31.7% |
| Toekomstig rendement op eigen vermogen | n/a |
| Dekking van analisten | Good |
| Laatst bijgewerkt | 14 May 2026 |
Recente toekomstige groei-updates
Recent updates
Narratiefupdate • May 18
CORZ: AI Data Center Power Expansion Is Expected To Drive Upside
Analysts have lifted the Core Scientific price target to about $36.26 from $35.84, citing strong AI data center demand, expanded approved power capacity and improving high performance compute economics as key drivers of their updated assumptions. Analyst Commentary Recent research points to a broadly positive tone around Core Scientific, with several bullish analysts lifting price targets and highlighting AI related opportunities as key drivers in their models.Seeking Alpha • May 14
Core Scientific: AI Beneficiary Status Is Proven, But Shares Retest Prior Highs
Summary CORZ has executed a brilliant reversal from the prior bankruptcy in 2022, as they deliver a successful diversification across bitcoin mining and HPC operations. Their FQ1 '26 results show colocation revenue up +801% YoY with notable gross margin expansion, and further top/bottom-line outperformance is likely as they ramp up their power capacity. Despite the recent rally and the elevated EV/Sales of 13.55x, CORZ’s expanding power capacity of up to 3 GW supports their compelling high-growth prospects, pending new customer agreements. Given the overbought rally, I recommend patience for a moderate pullback to the $18s, with those levels offering the more attractive entry point and the improved margin of safety. CORZ is downgraded to a Hold here. Read the full article on Seeking AlphaNarratiefupdate • May 02
CORZ: AI Hosting Shift And Power Expansion Are Expected To Drive Upside
Analysts have raised their average price target for Core Scientific by about $0.20, citing updated modeling that reflects refined fair value estimates, revised profit margin and revenue growth assumptions, and recent research highlighting power capacity additions, AI hosting expansion and an active lease pipeline. Analyst Commentary Recent research on Core Scientific has leaned positive, with several bullish analysts adjusting price targets higher and pointing to execution on growth initiatives, particularly in high performance computing and AI hosting.Narratiefupdate • Apr 18
CORZ: AI Hosting Ramp And Power Buildout Are Expected To Drive Upside
Analysts have adjusted the Core Scientific fair value estimate from $37.43 to $35.65, reflecting updated assumptions around higher projected revenue growth and profit margins, along with a lower future P/E multiple and a slightly refined discount rate based on recent research highlighting progress in AI hosting capacity, lease expectations, and HPC expansion. Analyst Commentary Recent Street research points to generally constructive sentiment around Core Scientific, with several bullish analysts refining models as new information comes through on AI hosting progress, lease timing, and high performance computing capacity.
Narratiefupdate • Apr 03
CORZ: AI Hosting Contracts And Power Expansion Will Drive Future Upside
Analysts have raised their blended price target on Core Scientific by a few dollars, placing it in the low to mid $20s. They cite progress on AI hosting contracts, expanded power capacity, and an ongoing shift in the power portfolio from Bitcoin mining toward high performance compute.Narratiefupdate • Mar 20
CORZ: AI Hosting Shift And Lease Pipeline Will Drive Future Upside
Analysts have nudged the Core Scientific price target slightly lower, with the updated fair value estimate moving from about $26.82 to $26.40. They are weighing higher projected revenue growth and profit margins against revised P/E assumptions and recent research highlighting organic growth plans, AI hosting expansion and an evolving lease pipeline.
Narratiefupdate • Mar 06
CORZ: AI Hosting Expansion And Texas Power Capacity Will Drive Future Upside
Analysts lifted their Core Scientific fair value estimate to $20 from $17, pointing to progress on new Texas capacity, AI hosting expansion, and expectations around additional lease signings as key drivers behind the higher price target range across recent research updates. Analyst Commentary Street research on Core Scientific has been active, with several firms updating their views around the company’s shift toward AI and high performance compute hosting, the timing of new lease signings, and the evolving power portfolio.Narratiefupdate • Feb 19
CORZ: Power Shift To High Performance Compute Will Support Future Contracts
Analysts have lifted their $-denominated price targets on Core Scientific, with one firm increasing its view by $6. They point to steadier discount rate assumptions, slightly higher projected revenue growth and margins, and a lower future P/E multiple supported by expectations for additional high performance compute contracts after the failed CoreWeave merger.Narratiefupdate • Feb 05
CORZ: Power Footprint Conversion To High Performance Compute Will Drive Next Phase
Analysts have trimmed their fair value estimate for Core Scientific from US$37.71 to US$37.43, citing updated assumptions around discount rates, revenue growth, margins and future P/E after recent price target changes and research highlighting both regulatory risks for crypto and potential long term upside from high performance computing contracts. Analyst Commentary Recent Street research around Core Scientific has highlighted a mix of crypto related policy risk and optimism around the company’s push into high performance computing, with some research pointing to potential valuation upside if execution on new contracts goes to plan.Narratiefupdate • Jan 22
CORZ: Future Compute Contracts And Crypto Exposure Balance Fair Opportunity And Risk
Narrative Update The analyst price target for Core Scientific has shifted from US$15.00 to US$17.00 as analysts factor in improved profit margin assumptions, a lower modeled discount rate, and recent research that points to potential value creation from the company pursuing high performance compute contracts following the terminated CoreWeave merger. Analyst Commentary Recent research coverage has shifted toward a more constructive tone on Core Scientific, with several firms lifting ratings and price targets following the terminated CoreWeave merger and increased focus on high performance compute opportunities.Narratiefupdate • Jan 07
CORZ: Power Footprint And HPC Contracts Will Define Next Phase
Narrative Update: Core Scientific Analyst Price Target Move The analyst price target for Core Scientific has shifted from roughly US$23.00 to about US$37.71. Analysts attribute this change to the resolution of the CoreWeave merger overhang, a renewed focus on high performance compute colocation contracts, and the perceived value of the company’s power infrastructure.Narratiefupdate • Dec 14
CORZ: Standalone AI Power Pipeline Will Drive Future Upside Potential
Analysts have trimmed their fair value estimate for Core Scientific by about $0.83 per share to $26.82, reflecting a slightly higher discount rate even as they highlight improved standalone prospects, reduced deal overhang, and stronger AI infrastructure optionality as key supports for the updated price target. Analyst Commentary Recent Street research reflects a largely constructive shift in sentiment on Core Scientific, with multiple firms raising ratings and price targets as the market pivots to a standalone, AI and high performance compute oriented narrative following the termination of the CoreWeave merger.Narratiefupdate • Nov 30
CORZ: Terminated Merger Will Unlock New Upside With Power Pipeline Expansion
Analysts have modestly raised their price target for Core Scientific to $27 from $23, citing the terminated merger and increased confidence in the company’s standalone prospects as key factors supporting improved valuation. Analyst Commentary Recent street research reflects a range of perspectives on Core Scientific's prospects as a standalone company, especially after the terminated merger.Narratiefupdate • Nov 16
CORZ: Standalone Operator Status Will Unlock New Upside This Year
Analysts have increased their fair value price target for Core Scientific from $25.25 to $27.65. They cite renewed confidence in the company's standalone prospects and the removal of merger-related overhangs as reasons for this adjustment.Narratiefupdate • Nov 01
CORZ: Power Portfolio And AI Demand Will Unlock Substantial Upside
Core Scientific's analyst price target has increased significantly from $20.88 to $25.25 per share. This change reflects analysts' optimism following the terminated merger with CoreWeave and improved standalone growth prospects for the company.Narratiefupdate • Oct 18
HPC Expansion And Diversified Contracts Will Create Future Resilience
Analysts have raised their price target for Core Scientific from $19.95 to $20.88 per share, citing strong sector momentum from major data center deals and an improved profit margin outlook. Analyst Commentary Analyst discussions surrounding Core Scientific have highlighted both promising industry dynamics and company-specific considerations that could influence future performance and valuation.Narratiefupdate • Oct 04
HPC Expansion And Diversified Contracts Will Create Future Resilience
Analysts have raised their price target for Core Scientific from $19.05 to $19.95 per share, citing updated deal terms and ongoing re-evaluation of merger economics following CoreWeave's acquisition agreement. Analyst Commentary Analysts continue to weigh the implications of Core Scientific's pending acquisition by CoreWeave, with a mix of optimism for the company's positioning and caution regarding valuation and deal structure.Narratiefupdate • Aug 27
HPC Expansion And Diversified Contracts Will Create Future Resilience
Consensus analyst price targets for Core Scientific have risen slightly to reflect the strategic value of its infrastructure assets highlighted by the announced CoreWeave acquisition, despite some uncertainty regarding realized shareholder value and potential downside to deal economics, resulting in a revised fair value of $19.05. Analyst Commentary The announced acquisition of Core Scientific by CoreWeave in an all-stock transaction prompted widespread price target reductions and downgrades to Neutral/Hold/Perform, reflecting diminished standalone upside and uncertainty regarding the ultimate value realized by Core Scientific shareholders.
Nieuw narratief • Apr 23
HPC Expansion And Diversified Contracts Will Create Future Resilience
Reallocating resources from Bitcoin mining to HPC infrastructure could drive future growth amid rising data center demands and diversified clientele.Seeking Alpha • Mar 18
The AI Awakening Of Core Scientific
Summary Core Scientific's pivot from bitcoin mining to AI infrastructure, securing $10.2 billion in long-term contracts, offers a stable revenue stream and significant growth potential. The recent stock price decline due to speculative concerns presents a compelling investment opportunity, with a conservative valuation indicating a 64% upside. CoreWeave's $12 billion contract with OpenAI reaffirms strong demand for AI infrastructure, mitigating fears over Microsoft's commitment and reinforcing CORZ's business model. Insider purchases at $8 per share and ongoing HPC contract announcements validate confidence in CORZ’s future prospects amidst AI-driven compute demand growth. Read the full article on Seeking AlphaSeeking Alpha • Mar 09
DeepSeek, Market Volatility, False Rumor Create Opportunity In Core Scientific
Summary Core Scientific shares are undervalued due to market volatility and false rumors about Microsoft canceling leases with CoreWeave, presenting a significant investment opportunity. CORZ has $10.2B in future contracted revenue with high margins and management expects critical IT load to more than double by 2028. Positive developments include issuing $1B in convertible notes, completing significant contracts, and insider buying, indicating confidence in the company's future. Risks include customer concentration with CoreWeave, but management is focused on diversifying to mitigate this. Read the full article on Seeking AlphaSeeking Alpha • Jan 12
Core Scientific: Higher Digital Asset Prices And Making Progress On Debt
Summary Core Scientific's strategic pivot to high-performance computing (HPC) has driven significant stock appreciation, despite volatility and challenges in the Bitcoin mining market. The company recorded a $40.7 million operating loss in Q3 2024, mainly due to decreased revenues and increased SG&A expenses. Core Scientific's refinancing efforts have reduced debt and interest expenses, providing insulation against higher interest rates and improving liquidity. The partnership with CoreWeave is expected to yield significant revenue, positioning Core Scientific favorably in the AI infrastructure market. Given the high level of market expectations, one may expect volatility as it executes on AI. Read the full article on Seeking AlphaSeeking Alpha • Oct 16
Core Scientific: HPC Pivot Begins To Bear Fruit
Summary Core Scientific's stock has nearly doubled since June, outperforming the market and tech giants like NVIDIA. Despite a significant debt reduction and improved balance sheet, Core Scientific's growth heavily relies on its relationship with CoreWeave, raising concerns about client diversification. Bitcoin mining remains Core Scientific's primary revenue source, but declining BTC production and high operational costs highlight the need for growth in the HPC segment. The delay in CoreWeave's 118 MW option and the lack of additional HPC clients make me cautious about investing in Core Scientific at this time. Read the full article on Seeking AlphaSeeking Alpha • Aug 13
Core Scientific: Deserves Better As HPC Moves Into High Gear
Summary Despite having seen its share price fluctuating alongside Bitcoin since the halving event, Core Scientific has nonetheless delivered a net upside of 200%. Still, it is underpriced based on potential revenues to be obtained from HPC or High-Performance Computing leasing. Also, volatility is likely to continue in the short term due to predominant exposure to digital assets, but the strong operational performance and HPC focus are key advantages. Also, it bears high debt, but continued diversification into hosting versus self-mining means more stable cash flow generation. The company achieved milestones, leased a data center in Austin, and secured a contract with CoreWeave for 382 megawatts, with potential revenue of $6.7 billion. Read the full article on Seeking AlphaSeeking Alpha • Jun 04
Core Scientific: HPC Deals And A Buyout Offer
Summary After a rollercoaster ride for CORZ shareholders that included a delisting, bankruptcy, and relisting, a lifeline has been offered. Core Scientific is the latest Bitcoin miner to get a buyout offer from a suitor, this one coming from the company's HPC hosting customer. Bitcoin mining fundamentals are questionable going forward and there are still over $1 billion in total liabilities. Read the full article on Seeking AlphaWinst- en omzetgroeiprognoses
| Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
|---|---|---|---|---|---|
| 12/31/2028 | 1,363 | 573 | -2,000 | 691 | 3 |
| 12/31/2027 | 1,036 | 222 | -1,486 | 541 | 12 |
| 12/31/2026 | 622 | -295 | -713 | 460 | 13 |
| 3/31/2026 | 355 | -1,072 | -471 | 573 | N/A |
| 12/31/2025 | 319 | -281 | -461 | 278 | N/A |
| 9/30/2025 | 334 | -275 | -354 | 135 | N/A |
| 6/30/2025 | 348 | -470 | -257 | 8 | N/A |
| 3/31/2025 | 411 | -1,007 | -172 | -24 | N/A |
| 12/31/2024 | 511 | -1,245 | -52 | 43 | N/A |
| 9/30/2024 | 558 | -1,133 | -27 | 51 | N/A |
| 6/30/2024 | 575 | -831 | 1 | 51 | N/A |
| 3/31/2024 | 561 | -35 | 20 | 67 | N/A |
| 12/31/2023 | 502 | -246 | 48 | 65 | N/A |
| 9/30/2023 | 482 | -486 | 14 | 159 | N/A |
| 6/30/2023 | 531 | -879 | -46 | 102 | N/A |
| 3/31/2023 | 568 | -1,681 | -95 | 229 | N/A |
| 12/31/2022 | 640 | -2,146 | -386 | 205 | N/A |
| 9/30/2022 | 821 | -1,651 | -195 | 199 | N/A |
| 6/30/2022 | 771 | -1,233 | -260 | 206 | N/A |
| 3/31/2022 | 683 | -426 | -393 | -76 | N/A |
| 12/31/2021 | 544 | 47 | -116 | -57 | N/A |
| 9/30/2021 | 266 | -16 | -294 | -172 | N/A |
| 6/30/2021 | 163 | -1 | -178 | -130 | N/A |
| 3/31/2021 | 94 | -6 | -24 | -3 | N/A |
| 12/31/2020 | 60 | -23 | -25 | -24 | N/A |
| 12/31/2019 | 60 | -12 | N/A | -1 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: Er wordt voorspeld dat CORZ de komende 3 jaar winstgevend zal worden, wat wordt beschouwd als een snellere groei dan de spaarquote ( 3.5% ).
Winst versus markt: Er wordt verwacht dat CORZ de komende 3 jaar winstgevend zal worden. Dit wordt gezien als een groei die boven het gemiddelde van de markt ligt.
Hoge groeiwinsten: Er wordt verwacht dat CORZ binnen 3 jaar winstgevend zal worden.
Omzet versus markt: De omzet van CORZ ( 31.7% per jaar) zal naar verwachting sneller groeien dan de markt US ( 11.7% per jaar).
Hoge groei-inkomsten: De omzet van CORZ ( 31.7% per jaar) zal naar verwachting sneller groeien dan 20% per jaar.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Onvoldoende gegevens om te bepalen of het rendement op eigen vermogen van CORZ naar verwachting over 3 jaar hoog zal zijn
Ontdek groeibedrijven
Bedrijfsanalyse en status van financiële gegevens
| Gegevens | Laatst bijgewerkt (UTC-tijd) |
|---|---|
| Bedrijfsanalyse | 2026/05/19 21:43 |
| Aandelenkoers aan het einde van de dag | 2026/05/19 00:00 |
| Inkomsten | 2026/03/31 |
| Jaarlijkse inkomsten | 2025/12/31 |
Gegevensbronnen
De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.
| Pakket | Gegevens | Tijdframe | Voorbeeld Amerikaanse bron * |
|---|---|---|---|
| Financiële gegevens bedrijf | 10 jaar |
| |
| Consensus schattingen analisten | +3 jaar |
|
|
| Marktprijzen | 30 jaar |
| |
| Eigendom | 10 jaar |
| |
| Beheer | 10 jaar |
| |
| Belangrijkste ontwikkelingen | 10 jaar |
|
* Voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige formulieren en bronnen gebruikt.
Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Meer informatie.
Analysemodel en Snowflake
Details van het analysemodel dat is gebruikt om dit rapport te genereren zijn beschikbaar op onze Github-pagina. We hebben ook handleidingen over hoe je onze rapporten kunt gebruiken en tutorials op YouTube.
Leer meer over het team van wereldklasse dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.
Industrie en sector
Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op Github.
Bronnen van analisten
Core Scientific, Inc. wordt gevolgd door 21 analisten. 13 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.
| Analist | Instelling |
|---|---|
| Ramsey El-Assal | Barclays |
| Gautam Chhugani | Bernstein |
| Nicholas Giles | B. Riley Securities, Inc. |